Tyreman N O, Andersson P O, Kroon L, Orstam S
Acta Obstet Gynecol Scand. 1986;65(7):731-3. doi: 10.3109/00016348609161491.
One hundred and nine consecutive patients undergoing surgery for uterovaginal prolapse followed by indwelling urinary catheter for 3 days were randomized for prophylactic treatment with methenamine hippurate (MH) or no MH prophylaxis. Significantly less bacteriuria occurred in the MH-treated patient group. In particular, the opportunistic hospital flora appeared to be suppressed by MH treatment. It is suggested that MH prophylaxis, 1 g three times daily, be used in gynecological surgery followed by short-term urinary catheterization.
109例因子宫阴道脱垂接受手术并留置导尿管3天的连续患者被随机分为两组,一组接受马尿酸乌洛托品(MH)预防性治疗,另一组不进行MH预防。接受MH治疗的患者组菌尿发生率显著较低。特别是,MH治疗似乎抑制了医院机会性菌群。建议在妇科手术后短期留置导尿管的情况下,使用MH进行预防,每日3次,每次1g。